Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman et al. · Annals of Internal Medicine · 2013 · 7.4K citations · Full text

Clinical Endpoint, Trial Protocols, Clinical Guidelines +16

Validity and Reliability of the Reflux Symptom Index (RSI)

Peter C. Belafsky, Gregory N. Postma, James A. Koufman · Journal of Voice · 2002 · 1.5K citations

Functional Gastrointestinal Disorder, Reflux Symptom Index, Diagnostic Criterion +7

The Validity and Reliability of the Reflux Finding Score (RFS)

Peter C. Belafsky, Gregory N. Postma, James A. Koufman · The Laryngoscope · 2001 · 1.1K citations · Full text

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of <scp>TAK</scp>‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

Helen Jenkins, Yuichi Sakurai, Akira Nishimura et al. · Alimentary Pharmacology & Therapeutics · 2015 · 294 citations · Full text

Proton Pump Inhibitor Therapy for Chronic Laryngo‐Pharyngitis: A Randomized Placebo‐Control Trial

David L. Steward, Keith Wilson, Dan Kelly et al. · Otolaryngology · 2004 · 199 citations